References
- Napolitano M, Megna M, Timoshchuk EA, et al. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017;10:105–115.
- Davis SA, Lin HC, Balkrishnan R, et al. Hidradenitis suppurativa management in the United States: an analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases. Skin Appendage Disord. 2015;1(2):65–73.
- Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis. 2019;10:2040622319830646.
- Savage KT, Gonzalez Brant E, Flood KS, et al. Publication trends in hidradenitis suppurativa from 2008 to 2018. J Eur Acad Dermatol Venereol. 2020;34(9):1885–1889.
- Approval Package for: APPLICATION NUMBER: 125057Orig1s393: U.S. Food and Drug Administration, Center for Drug Evaluation and Research; [cited 2020 Jun 6]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/125057Orig1s393.pdf.
- Understanding and Interpreting the National Hospital Ambulatory Medical Care Survey (NHAMCS): Key Questions and Answers [cited 2020 Apr 22]. Available from: https://www.cdc.gov/nchs/data/ahcd/annals_emerg_med_q_and_a_nchs_web_version.pdf.
- National Ambulatory Medical Care Survey CDC; 2016. [cited 2020 Apr 20]. Available from: https://www.cdc.gov/nchs/ahcd/datasets_documentation_related.htm.
- Muddasani S, Fleischer AB. Jr. United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitors. J Dermatolog Treat. 2020:1–3. doi:10.1080/09546634.2020.1729951
- ICD-9-CM diagnosis and procedure codes: abbreviated and full code titles [cited 2020 May 29]. Available from: https://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/codes.
- ICD-10-CM official guidelines for coding and reporting: CDC; 2020. Available from: https://www.cdc.gov/nchs/data/icd/10cmguidelines-FY2020_final.pdf.
- Group USC. Introduction to SAS. Available from: https://stats.idre.ucla.edu/sas/output/proc-logistic/.
- 2016 Micro-Data File Documentation [cited 2020 Apr 28]. Available from: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NAMCS/doc2016.pdf.
- Fischer AH, Haskin A, Okoye GA. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa. J Am Acad Dermatol. 2017;76(2):309–313.e2.
- Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part i: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90.
- Arun B, Loffeld A. Long-standing hidradenitis suppurativa treated effectively with metformin. Clin Exp Dermatol. 2009;34(8):920–921.
- Jennings L, Hambly R, Hughes R, et al. Metformin use in hidradenitis suppurativa. J Dermatolog Treat. 2020;31(3):261–263.
- Lopes S, Vide J, Costa-Silva M, et al. Awareness, knowledge, and practice patterns of general practitioner residents and specialists toward hidradenitis suppurativa: a survey study. Acta Dermatovenerol Alp Pannonica Adriat. 2019;28(2):61–63.
- Grant A, Gonzalez T, Montgomery MO, et al. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. J Am Acad Dermatol. 2010;62(2):205–217.
- Fonia A, Jackson K, Lereun C, et al. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis. Br J Dermatol. 2010;163(4):807–816.
- Kimball AB, Sundaram M, Shields AL, et al. Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials. J Am Acad Dermatol. 2018;79(6):1141–1143.
- Garg A, Papagermanos V, Midura M, et al. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States. J Am Acad Dermatol. 2018;79(3):495–500.